ConductScience.org, home

Paper37243271

Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.

Ding S and 16 others. Viruses, 2023. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Papers, record 37243271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37243271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.
PubMed
Journal
Viruses
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.97
iCite
Revised in PubMed
2024-10-23
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ding SShilei
2Tolbert WDWilliam D
3Zhu HHuile
4Lee DDanielhttps://orcid.org/0000-0002-7322-1512
5Marchitto LLorie
6Higgins TTyler
7Zhao XXuchen
8Nguyen DDung
9Sherburn RRebekah
10Richard JJonathan
11Gendron-Lepage GGabrielle
12Medjahed HHalima
13Mohammadi MMohammadjavadhttps://orcid.org/0000-0001-7344-0857
14Abrams CCameron
15Pazgier MMarzenahttps://orcid.org/0000-0003-0594-5057
16Smith AB 3rdAmos B
17Finzi AAndrés

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV-1Major topic
HIV SeropositivityMajor topic
HIV InfectionsMajor topic
Humans
Epitopes
CD4-Positive T-Lymphocytes
CD4 Antigens
Antibody-Dependent Cell Cytotoxicity
HIV Envelope Protein gp120
HIV Antibodies

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI148379NIAID NIH HHSUnited StatesR01AI148379PubMed and NIHNIH RePORTER
P01 AI150471NIAID NIH HHSUnited StatesP01AI150471PubMedNIH RePORTER
R01 AI129769NIAID NIH HHSUnited StatesR01AI129769PubMed and NIHNIH RePORTER
P01 GM056550NIGMS NIH HHSUnited StatesP01GM056550PubMed and NIHNIH RePORTER
UM1 AI164562NIAID NIH HHSUnited StatesUM1AI164562PubMed and NIHNIH RePORTER
P01 AI162242NIAID NIH HHSUnited StatesP01AI162242PubMedNIH RePORTER
R01AI150322NIHNIH RePORTER
R01AI174908NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Update of36993184

Source PubMed

Download CSV of comments and corrections

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115299374The CCP4 suite: programs for protein crystallography.Acta Crystallogr D Biol Crystallogr1994https://conductscience.org/library/papers/15299374PubMed
222628654Linking crystallographic model and data quality.Science2012https://conductscience.org/library/papers/22628654PubMed
327754618Processing of X-ray diffraction data collected in oscillation mode.Methods Enzymol1997https://conductscience.org/library/papers/27754618PubMed
419939925Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies.J Virol2010https://conductscience.org/library/papers/19939925PubMed
526637462A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies.J Virol2016https://conductscience.org/library/papers/26637462PubMed
618488318Free R value: cross-validation in crystallography.Methods Enzymol1997https://conductscience.org/library/papers/18488318PubMed
732184972Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.ACS Med Chem Lett2020https://conductscience.org/library/papers/32184972PubMed
829559570Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses.mBio2018https://conductscience.org/library/papers/29559570PubMed
924696475CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies.J Virol2014https://conductscience.org/library/papers/24696475PubMed
102986290Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.Science1985https://conductscience.org/library/papers/2986290PubMed
1132457241The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.mBio2020https://conductscience.org/library/papers/32457241PubMed
1229350181A single, continuous metric to define tiered serum neutralization potency against HIV.Elife2018https://conductscience.org/library/papers/29350181PubMed
1327846736
Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates.
AIDS Res Hum Retroviruses2017https://conductscience.org/library/papers/27846736PubMed
1416051803Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines.J Virol2005https://conductscience.org/library/papers/16051803PubMed
1531554684A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity.J Virol2019https://conductscience.org/library/papers/31554684PubMed
169632381The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.Science1998https://conductscience.org/library/papers/9632381PubMed
1730974085An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity.Cell Host Microbe2019https://conductscience.org/library/papers/30974085PubMed
1829915222A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge.Nat Commun2018https://conductscience.org/library/papers/29915222PubMed
1925339767The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals.J Virol2015https://conductscience.org/library/papers/25339767PubMed
2019000821Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120.Structure2008https://conductscience.org/library/papers/19000821PubMed

See all 42 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
41583464Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection.Front Immunol2025https://conductscience.org/library/papers/41583464PubMed
41326374The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.Nat Commun2025https://conductscience.org/library/papers/41326374PubMed
39563795Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity.ACS Med Chem Lett2024https://conductscience.org/library/papers/39563795PubMed
39248460The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity.J Virol2024https://conductscience.org/library/papers/39248460PubMed
38895270The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity.bioRxiv2024https://conductscience.org/library/papers/38895270PubMed
37888980V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins.J Virol2023https://conductscience.org/library/papers/37888980PubMed
37872202Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir.Nat Commun2023https://conductscience.org/library/papers/37872202PubMed

Download CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AD8353128PubTator's text mininghttps://conductscience.org/library/genes/353128NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CYTH19267PubTator's text mininghttps://conductscience.org/library/genes/9267NCBI Gene
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700NCBI Gene
NRSN1140767PubTator's text mininghttps://conductscience.org/library/genes/140767NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37243271

GET https://conductscience.org/api/papers/v1/37243271/references?page=2